These findings were supported by the concurrent meta-analysis, which revealed that the presence of TMPRSS2:ERG fusion increased the risk of a higher tumor stage at diagnosis but did not correlate with the final outcome [40]. The gene discussed is ERG; the disease is neoplasm.